Redistribution of H3K4me2 on neural tissue specific genes during mouse brain development

BackgroundHistone modification plays an important role in cell differentiation and tissue development. A recent study has shown that the dimethylation of lysine 4 residue on histone 3 (H3K4me2) marks the gene body area of tissue specific genes in the human CD4+ T cells and neural cells. However, little is known of the H3k4me2 distribution dynamics through the cell differentiation and tissue development.ResultsWe applied several clustering methods including K-means, hierarchical and principle component analysis on H3K4me2 ChIP-seq data from embryonic stem cell, neural progenitor cell and whole brain of mouse, trying to identify genes with the H3K4me2 binding on the gene body region in different cell development stage and study their redistribution in different tissue development stages.A cluster of 356 genes with heavy H3K4me2 labeling in the gene body region was identified in the mouse whole brain tissue using K-means clustering. They are highly enriched with neural system related functions and pathways, and are involved in several central neural system diseases. The distribution of H3K4me2 on neural function related genes follows three distinctive patterns: a group of genes contain constant heavy H3K4me2 marks in the gene body from embryonic stem cell stage through neural progenitor stage to matured brain tissue stage; another group of gene have little H3K4me2 marks until cells mature into brain cells; the majority of the genes acquired H3K4me2 marks in the neural progenitor cell stage, and gain heavy labeling in the matured brain cell stage. Gene ontology enrichment analysis also revealed corresponding gene ontology terms that fit in the scenario of each cell developmental stages.ConclusionsWe investigated the process of the H3K4me2 mark redistribution during tissue specificity development for mouse brain tissue. Our analysis confirmed the previous report that heavy labeling of H3K4me2 in the downstream of TSS marks tissue specific genes. These genes show remarkable enrichment in central neural system related diseases. Furthermore, we have shown that H3K4me2 labeling can be acquired as early as the embryonic stem cell stage, and its distribution is dynamic and progressive throughout cell differentiation and tissue development.

[1]  J. Han,et al.  Inferring causal relationships among different histone modifications and gene expression. , 2008, Genome research.

[2]  Salvatore Spicuglia,et al.  A unique H3K4me2 profile marks tissue-specific gene regulation. , 2010, Genome research.

[3]  Roland Green,et al.  Genome-scale ChIP-chip analysis using 10,000 human cells. , 2007, BioTechniques.

[4]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[5]  Kenneth P. Nephew,et al.  RNA Polymerase II Binding Patterns Reveal Genomic Regions Involved in MicroRNA Gene Regulation , 2010, PloS one.

[6]  Anthony P. Fejes,et al.  Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. , 2008, Genome research.

[7]  K. Tan,et al.  Combinatorial chromatin modification patterns in the human genome revealed by subspace clustering , 2011, Nucleic acids research.

[8]  Manolis Kellis,et al.  Discovery and characterization of chromatin states for systematic annotation of the human genome , 2010, Nature Biotechnology.

[9]  Zhiping Weng,et al.  Statistical analysis of the genomic distribution and correlation of regulatory elements in the ENCODE regions. , 2007, Genome research.

[10]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[11]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[12]  Janet Rossant,et al.  Distinct histone modifications in stem cell lines and tissue lineages from the early mouse embryo , 2010, Proceedings of the National Academy of Sciences.

[13]  Clifford A. Meyer,et al.  Nucleosome Dynamics Define Transcriptional Enhancers , 2010, Nature Genetics.

[14]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[15]  D. Gold,et al.  Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation , 2008, Nature Genetics.

[16]  E. Mardis.  ChIP-seq: welcome to the new frontier , 2007, Nature Methods.

[17]  Philipp Bucher,et al.  ChIP-Seq Data Reveal Nucleosome Architecture of Human Promoters , 2007, Cell.

[18]  Bing Ren,et al.  ChIP‐chip for Genome‐Wide Analysis of Protein Binding in Mammalian Cells , 2007, Current protocols in molecular biology.